VENTRICULAR ARRHYTHMIAS 2002 Cardiovascular Conference Report Recommendation Tables, Page 98 PHYSIOLOGY/ DIAGNOSIS CERTIFICATION RE-CERTIFICATION FUNCTIONAL Coronary Heart Disease Sustained VT: No (CHD) Poor prognosis and high risk. NSVT, LVEF < 0.40: No Unfavorable prognosis. NSVT, LVEF >0.40: No, if symptomatic. Generally considered to have good prognosis. Yes if: Annual Asymptomatic. Cardiology examination At least 1 month after required. drug or other therapy is successful; Cleared by cardiologist. Dilated Cardiomyopathy NSVT (LVEF < 0.40). No Sustained VT, any LVEF. No Syncope/near syncope, No any LVEF: High risk. Hypertrophic Variable but uncertain No Cardiomyopathy prognosis.
VENTRICULAR ARRHYTHMIAS 2002 Cardiovascular Conference Report Recommendation Tables, Page 98 DIAGNOSIS PHYSIOLOGY/ FUNCTIONAL CERTIFICATION RE-CERTIFICATION Coronary Heart Disease (CHD) Sustained VT: Poor prognosis and high risk. NSVT, LVEF < 0.40: Unfavorable prognosis. NSVT, LVEF >0.40: Generally considered to have good prognosis. No No No, if symptomatic. Yes if: Asymptomatic. At least 1 month after drug or other therapy is successful; Cleared by cardiologist. Annual Cardiology examination required. Dilated Cardiomyopathy NSVT (LVEF < 0.40). Sustained VT, any LVEF. Syncope/near syncope, any LVEF: High risk. No No No Hypertrophic Cardiomyopathy Variable but uncertain prognosis. No